Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Change in Accured Expenses (2022 - 2025)

Praxis Precision Medicines has reported Change in Accured Expenses over the past 4 years, most recently at $14.4 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 78.01% year-over-year to $14.4 million; the TTM value through Dec 2025 reached $11.2 million, down 30.48%, while the annual FY2025 figure was $11.2 million, 30.48% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was $14.4 million at Praxis Precision Medicines, up from $1.6 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $14.4 million in Q4 2025 and troughed at -$8.3 million in Q1 2025.
  • A 4-year average of $521750.0 and a median of $976000.0 in 2023 define the central range for Change in Accured Expenses.
  • Biggest five-year swings in Change in Accured Expenses: surged 2067.11% in 2024 and later plummeted 1261.84% in 2025.
  • Year by year, Change in Accured Expenses stood at -$2.0 million in 2022, then skyrocketed by 118.39% to $374000.0 in 2023, then surged by 2067.11% to $8.1 million in 2024, then soared by 78.01% to $14.4 million in 2025.
  • Business Quant data shows Change in Accured Expenses for PRAX at $14.4 million in Q4 2025, $1.6 million in Q3 2025, and $3.5 million in Q2 2025.